Dr. Lynn R. Goldman, Michael and Lori Milken Dean of George Washington University Milken Institute School of Public Health, recently testified about the impacts of a proposed U.S. Environmental Protection Agency (EPA) rule to the agency’s Science Advisory Board.
The EPA Science Advisory Board was created by Congress 40 years ago to review the quality and relevance of the scientific and technical information being used by the EPA or proposed as the basis of agency regulations. Dr. Goldman responded to a recent memo recommending that the Science Advisory Board review the agency’s proposed rule, “Strengthening Transparency in Regulatory Science.”
The rule would require that the underlying data for all scientific studies used by EPA to assess the risk to human health posed by exposure to varying doses of environmental chemicals be publicly available. This requirement would sharply limit the number of studies available for consideration because much research relies on confidential health data from study subjects.
“By restricting access to data and causing delays in EPA processes, this proposal threatens EPA’s ability to protect public health and the environment,” Dr. Goldman said. “The proposed rule is a dramatic departure from how the EPA and other U.S. regulatory agencies, and similar agencies internationally, develop dose response assessments in the context of regulatory decisions.”
Dr. Goldman’s deep public policy and academic experience includes serving from 1993 to 1998 as the EPA’s assistant administrator for what is now called the Office of Chemical Safety and Pollution Prevention.